Z
Zurimed Technologies
Zurimed Technologies create revolutionary devices for ligament reconstruction
About Zurimed Technologies
ZuriMED Technologies AG is a Swiss-based company specializing in advanced medical technologies aimed at revolutionizing soft tissue repair in orthopaedic sports medicine. The company focuses on developing breakthrough technologies and products that enhance the quality of treatment and ultimately improve the quality of life for patients. ZuriMED's primary product, the FiberLocker System, is designed to augment rotator cuff repair, a common issue in sports medicine.
Founded in 2015, ZuriMED has garnered significant recognition, including winning the Venture Kick Final and being named the 2nd best business plan by Venture, a leading competition for entrepreneurs in Switzerland. The company operates in the highly specialized market of orthopaedic sports medicine, serving healthcare providers and medical institutions that require advanced solutions for soft tissue repair.
ZuriMED's business model revolves around the development, clinical validation, and commercialization of its innovative medical technologies. The company generates revenue through the sale of its products to medical institutions and healthcare providers. Additionally, ZuriMED has secured funding through various channels, including a successful Series A financing round that raised 14.5 million CHF, and grants from organizations such as Innosuisse.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Zurich, Switzerland
- Employees
- 42
- Open positions
- None listed
- Dealroom signal
- 89.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Spinout, Hard Tech, DT and LS, science-based, Swiss DT MedTech
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Aug 2026 | $0 | — | Stryker | ↗ |
| SUPPORT PROGRAM✓Other financing | Jan 2024 | $0 | — | Swissnex | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Zurimed Technologies is 870 monthly website visits, down 56.5% over the last three months. Zurimed Technologies's team grew 10.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Venture Kick
ETH Foundation
Innosuisse
Series A2 investors entered at this stage
Chindex Medical
Yellowstone Holding
Other known investors5 additional known investors
ETH Zurich
Stryker
Swissnex
University of Zürich
VentureLab
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zurimed Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zurimed Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







